← BASF overview

BASF vs Indorama Ventures PCL: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BASF SE (BAS.XETRA)

Q3 2026
▲2▼1

BASF's mixed Q3: asset sale, buyback, AI bet, but Rhine and EU risks

  • Coatings sale completed BASF finished selling its coatings business to Carlyle for €7.7bn, boosting cash, profit, and earnings per share while keeping a 40% stake. This strengthens the balance sheet and supports shareholder returns.

    Major completed deal that directly improved financials and cash flow.

  • AI investment and buyback BASF invested $1.1bn in AI for medical plastics and started a €1bn share buyback. These moves aim to drive future growth and return cash to shareholders, signaling confidence.

    New strategic investments and capital returns that could lift investor sentiment.

  • Rhine water and EU emissions risks Record-low Rhine water levels threaten production and raw-material supplies, while an EU emissions overhaul could raise costs. These factors create operational and regulatory uncertainty.

    Key external risks that could disrupt operations and increase expenses.

  • Evonik takeover talks BASF proposed a €12bn takeover of Evonik, which could create a European chemicals giant, but talks are early and shares fell nearly 2% on integration and funding concerns.

    Potential transformative deal with uncertain outcome and negative initial market reaction.

August 2026
▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

  • Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.

    This is the period's biggest positive fundamental news and directly supports the share price.

  • Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.

    It shows a broad industry pricing upturn that directly benefits BASF's earnings.

  • Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.

    This is a real operational risk that could hurt earnings and weigh on the stock.

  • Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.

    This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

Latest
▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

  • Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.

    This is the period's biggest positive fundamental news and directly supports the share price.

  • Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.

    It shows a broad industry pricing upturn that directly benefits BASF's earnings.

  • Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.

    This is a real operational risk that could hurt earnings and weigh on the stock.

  • Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.

    This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

July 2026
▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

  • Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.

    This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.

  • New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.

    A concrete new product launch that supports future revenue growth in a profitable segment.

  • AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.

    Shows BASF investing in technology that may improve margins and competitiveness over time.

  • EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.

    A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

  • Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.

    This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.

  • New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.

    A concrete new product launch that supports future revenue growth in a profitable segment.

  • AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.

    Shows BASF investing in technology that may improve margins and competitiveness over time.

  • EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.

    A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

Indorama Ventures PCL (IVL.BK)

Q3 2026
▲2▼2

Indorama Swings to Record Profit as Supply Disruptions Lift PET Spreads

  • Record Q2 profit ends loss streak Indorama posted a record quarterly net profit of 5,961 million baht, ending five straight loss quarters, as Middle East supply disruptions lifted PET and MEG spreads.

    This is the key new positive event that drove the stock in Q3.

  • Debt reduction and analyst upgrades Net debt fell to 226 billion baht and debt-to-equity improved to 1.56x, prompting CLSA, Yuanta, and Krungsri to name IVL a top pick, citing peak PET supply passing.

    Shows balance sheet improvement and positive analyst sentiment that supported the stock.

  • Downgrades and estimate cuts Morgan Stanley downgraded IVL to Underweight with a 19 baht target, warning returns stay below cost of capital, while JPMorgan cut it to Neutral and slashed 2027 estimates 32.6% on weaker spreads.

    Represents the main negative counterweight from analysts during the period.

  • Macro headwinds and spread risks Analysts warned spreads may soften as supply returns, and Fed rate hikes to 3.75–4.00% with Brent at $100 create a tug-of-war capping gains.

    Highlights external risks that limited upside despite strong earnings.

September 2026
▲3

IVL gains on record Q2, rising petrochemical spreads, and broker upgrades

  • Record Q2 profit and stronger balance sheet IVL reported Q2 net profit of 5,961 million baht, reversing a year-ago loss, with all four businesses contributing and PET spreads at $279/ton. Net debt fell to 226 billion baht and the debt-to-equity ratio improved to 1.56 times. This confirms the profit recovery is real and strengthens the balance sheet, supporting the shares.

    The record Q2 result is the fundamental proof behind the recovery story and directly supports the stock.

  • Petrochemical spreads rebound sharply, brokers switch into IVL Bualuang reported ethylene, propylene, HDPE and PP spreads all jumped, with PP up $164/ton, and recommended switching from refinery stocks into petrochemicals, picking IVL and PTTGC. Wider spreads mean IVL earns more per ton sold, directly lifting profit expectations and the share price.

    This is the clearest new evidence that IVL's core product margins are recovering, which is the main profit driver.

  • Earnings estimates and broker top picks raised September SET earnings estimates were revised up 0.7%, with IVL gaining 7% and petrochemicals leading at 6.2%. Krungsri then named IVL a Q4 2026 top pick and part of its energy security theme. Higher estimates and repeated broker endorsements pull money into the stock.

    Upward estimate revisions and top-pick status show analysts expect more profit and are steering buyers toward IVL.

  • High oil and Fed rate hike cut both ways Brent hit $100 and the Fed raised rates to 3.75-4.00%, pressuring growth stocks and the Thai market. But brokers still favor energy and petrochemicals, naming IVL, because high oil lifts chemical prices. The tug-of-war means rate worries cap gains while oil strength supports IVL.

    This is the main counterweight: rate hikes and expensive oil can hurt the broad market even as they help IVL's spreads.

Latest
▲3

IVL gains on record Q2, rising petrochemical spreads, and broker upgrades

  • Record Q2 profit and stronger balance sheet IVL reported Q2 net profit of 5,961 million baht, reversing a year-ago loss, with all four businesses contributing and PET spreads at $279/ton. Net debt fell to 226 billion baht and the debt-to-equity ratio improved to 1.56 times. This confirms the profit recovery is real and strengthens the balance sheet, supporting the shares.

    The record Q2 result is the fundamental proof behind the recovery story and directly supports the stock.

  • Petrochemical spreads rebound sharply, brokers switch into IVL Bualuang reported ethylene, propylene, HDPE and PP spreads all jumped, with PP up $164/ton, and recommended switching from refinery stocks into petrochemicals, picking IVL and PTTGC. Wider spreads mean IVL earns more per ton sold, directly lifting profit expectations and the share price.

    This is the clearest new evidence that IVL's core product margins are recovering, which is the main profit driver.

  • Earnings estimates and broker top picks raised September SET earnings estimates were revised up 0.7%, with IVL gaining 7% and petrochemicals leading at 6.2%. Krungsri then named IVL a Q4 2026 top pick and part of its energy security theme. Higher estimates and repeated broker endorsements pull money into the stock.

    Upward estimate revisions and top-pick status show analysts expect more profit and are steering buyers toward IVL.

  • High oil and Fed rate hike cut both ways Brent hit $100 and the Fed raised rates to 3.75-4.00%, pressuring growth stocks and the Thai market. But brokers still favor energy and petrochemicals, naming IVL, because high oil lifts chemical prices. The tug-of-war means rate worries cap gains while oil strength supports IVL.

    This is the main counterweight: rate hikes and expensive oil can hurt the broad market even as they help IVL's spreads.

August 2026
▼2▲1

IVL's Q2 profit rebound met by mixed analyst views and spread warnings

  • CLSA raises target to 32 baht CLSA increased its target price to 32 baht, citing peak PET supply passing. Yuanta maintained a Buy rating with a 27.50 baht target. These upgrades reflect optimism about improving market conditions.

    Analyst upgrades can boost investor confidence and attract buyers, directly influencing the stock price.

  • JPMorgan downgrades to Neutral JPMorgan downgraded IVL to Neutral, cutting its target to 22 baht and 2027 earnings estimates by 32.6% due to weaker MTBE/PET spreads. This downgrade signals concerns about future profitability.

    A major broker downgrade can negatively impact investor sentiment and put downward pressure on the stock price.

  • Warnings of softening spreads Yuanta and Bualuang warned that spreads may soften in Q3 as supply returns, potentially slowing the recovery. This could pressure margins and limit profit growth in the near term.

    These warnings highlight a potential headwind that could dampen the positive momentum from the Q2 profit recovery.

▲4

IVL jumps as brokers hike targets on PET supply peak and oil-driven spread recovery

  • CLSA raises target to 32 baht, sees PET supply peak passing CLSA lifted its IVL target to 32 baht from 28 and kept Outperform, saying 2026 is the last year of new PET capacity and Q3 spreads will beat expectations. A higher target from a major broker pulls the shares up because it signals the profit recovery has room to run.

    This is the single biggest new price catalyst in the period, directly lifting IVL shares 3.5%.

  • Oil spike and Venezuela OPEC exit talk lift petrochemical spreads Middle East tension pushed Dubai crude up about 5% to $93, and reports that Venezuela may leave OPEC raised hopes of more crude supply and cheaper feedstock. Analysts say petrochemical spreads have improved and recommend switching into IVL and PTTGC, pushing the shares up.

    It explains the fresh sector-wide buying that drove IVL's 4-6% jumps on Aug 28 and the broker energy lists.

  • Yuanta keeps Buy at 27.50 baht after record Q2 Yuanta maintained Buy with a 27.50 baht fair value, noting IVL's Q2 net profit of 6 billion baht was its best in 15 quarters and EBITDA grew across all businesses. The broker expects second-half slowdown is already priced in, so the shares rose 4.4% against the market.

    It is the first broker note in the period that re-anchors the stock to the strong Q2 result and sets the tone for later upgrades.

  • Thailand seen as supply-chain winner as production shifts to ASEAN IVL executives said geopolitical conflicts and trade wars are pushing factories to Thailand and ASEAN, and Thailand's petrochemical strengths and flexible supply chains are attracting investment. More regional production supports long-term demand for IVL's chemicals and packaging, a slow-building positive for the shares.

    It adds a structural demand tailwind that supports the bull case beyond short-term spread moves.

▲2▼2

IVL's Q2 profit rebound confirmed, but analysts split on what comes next

  • Q2 profit swing ends losing streak IVL reported a Q2 2026 net profit of 5.96 billion baht, reversing a year-earlier loss, with EBITDA up 129% and net debt cut to 226 billion baht ahead of target. A real profit plus faster debt reduction makes the recovery look solid, supporting the shares.

    The actual earnings result is the core new fact that validates the recovery story.

  • JPMorgan cuts target, sees valuation stretched JPMorgan downgraded IVL to Neutral and cut its target to 22 baht, slashing its 2027 earnings estimate by 32.6% on weaker MTBE and PET spreads and higher non-operating costs. This warns the strong quarter may not repeat, capping the upside.

    It is the main new counterweight to the bullish earnings news.

  • Petrochemical spreads soften as supply returns Yuanta said polyester petrochemical spreads fell week on week, and Bualuang expects Q3 prices and spreads to ease slightly as supply comes back. Lower spreads mean less profit per tonne, so the earnings recovery may slow even if levels stay above last year.

    It explains the near-term pressure on IVL's core product margins.

  • Suntory deal adds circular PET growth IVL partnered with Suntory and Iwatani to bring commercial circular PET packaging to Thailand, producing recycled preforms equal to about 400 million bottles a year, with deliveries from 2028. It strengthens the downstream packaging business and the IVL 2.0 growth plan.

    It is a new long-term demand driver for IVL's higher-value recycled products.

July 2026
▲3▼1

IVL's Q2 profit rebound meets a major broker downgrade

  • Q2 profit recovery on Middle East supply disruptions IVL expects a strong Q2 2026 profit of 6.7 billion baht, ending five straight loss quarters, as Middle East supply disruptions lifted PET and MEG spreads sharply. Higher spreads mean IVL earns more per tonne sold, directly boosting profit and supporting the stock.

    This is the core new fundamental driver of IVL's earnings and price outlook.

  • Brokers flag IVL as a top Q2 earnings standout Several Thai brokers expect IVL to post outstanding Q2 profit growth, with one forecasting a 983% year-on-year jump, and name it a top pick. Such endorsements can draw buyers and support the share price.

    Shows broad analyst recognition of the earnings rebound, reinforcing the positive case.

  • Rotation into petrochemicals on high oil prices Bualuang Securities recommends switching from refineries and electronics into lagging petrochemicals like IVL, as Middle East tensions push oil above $87 a barrel. Fund flows into the sector can lift IVL's price even before earnings fully recover.

    Highlights a new sector rotation that directly benefits IVL's demand for its shares.

  • Morgan Stanley downgrade to Underweight, target cut to 19 baht Morgan Stanley downgraded IVL to Underweight and slashed its target to 19 baht, warning that returns on capital stay below cost of capital and debt remains very high. The stock fell 8.7% as investors worried the profit recovery may not be enough to lift the valuation.

    This is the main new counterweight that directly pressured IVL's price and challenges the recovery story.

▲3▼1

IVL's Q2 profit rebound meets a major broker downgrade

  • Q2 profit recovery on Middle East supply disruptions IVL expects a strong Q2 2026 profit of 6.7 billion baht, ending five straight loss quarters, as Middle East supply disruptions lifted PET and MEG spreads sharply. Higher spreads mean IVL earns more per tonne sold, directly boosting profit and supporting the stock.

    This is the core new fundamental driver of IVL's earnings and price outlook.

  • Brokers flag IVL as a top Q2 earnings standout Several Thai brokers expect IVL to post outstanding Q2 profit growth, with one forecasting a 983% year-on-year jump, and name it a top pick. Such endorsements can draw buyers and support the share price.

    Shows broad analyst recognition of the earnings rebound, reinforcing the positive case.

  • Rotation into petrochemicals on high oil prices Bualuang Securities recommends switching from refineries and electronics into lagging petrochemicals like IVL, as Middle East tensions push oil above $87 a barrel. Fund flows into the sector can lift IVL's price even before earnings fully recover.

    Highlights a new sector rotation that directly benefits IVL's demand for its shares.

  • Morgan Stanley downgrade to Underweight, target cut to 19 baht Morgan Stanley downgraded IVL to Underweight and slashed its target to 19 baht, warning that returns on capital stay below cost of capital and debt remains very high. The stock fell 8.7% as investors worried the profit recovery may not be enough to lift the valuation.

    This is the main new counterweight that directly pressured IVL's price and challenges the recovery story.

© 2026 MarketIVWhy